Raia Drogasil S.A (SA:RADL3) — Stock Price

R$19.38 BRL
▼ -4.15% today

Raia Drogasil S.A (SA:RADL3) is currently trading at R$19.38 BRL, down 4.15% today. Over the past 52 weeks, shares have ranged between R$16.25 and R$27.00. This page tracks Raia Drogasil S.A's live share price on the SA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Raia Drogasil S.A (RADL3) market capitalisation.

Raia Drogasil S.A (RADL3) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Raia Drogasil S.A's daily closing share price and trading volume on the SA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Raia Drogasil S.A Income Statement — Revenue, Profit & Earnings by Year

Raia Drogasil S.A's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue R$44.25 Billion R$38.86 Billion R$33.97 Billion R$29.07 Billion R$24.13 Billion
Cost of Revenue R$33.30 Billion R$27.31 Billion R$23.77 Billion R$20.26 Billion R$18.21 Billion
Gross Profit R$10.95 Billion R$11.55 Billion R$10.21 Billion R$8.81 Billion R$7.21 Billion
Research & Development
SG&A R$1.57 Billion R$1.57 Billion R$1.50 Billion R$1.25 Billion R$912.33 Million
Total Operating Expenses R$8.31 Billion R$9.18 Billion R$8.13 Billion R$6.98 Billion R$4.51 Billion
Operating Income R$2.64 Billion R$2.37 Billion R$2.08 Billion R$1.84 Billion R$1.37 Billion
EBITDA R$4.65 Billion R$3.14 Billion R$2.75 Billion R$2.45 Billion R$2.60 Billion
EBIT R$2.64 Billion R$2.23 Billion R$1.95 Billion R$1.75 Billion R$1.31 Billion
Interest Expense R$1.07 Billion R$790.95 Million R$737.79 Million R$559.22 Million R$316.00 Million
Income Before Tax R$1.45 Billion R$1.42 Billion R$1.22 Billion R$1.19 Billion R$987.26 Million
Income Tax Expense R$147.81 Million R$206.51 Million R$129.55 Million R$178.24 Million R$223.13 Million
Net Income R$1.30 Billion R$1.20 Billion R$1.05 Billion R$996.11 Million R$751.93 Million

Raia Drogasil S.A Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Raia Drogasil S.A's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets R$25.47 Billion R$22.14 Billion R$20.09 Billion R$17.19 Billion R$14.78 Billion
Total Current Assets R$14.90 Billion R$12.70 Billion R$11.56 Billion R$9.58 Billion R$7.72 Billion
Cash & Equivalents R$287.39 Million R$331.49 Million R$234.75 Million R$315.07 Million R$214.99 Million
Short-term Investments R$19.12 Million R$15.71 Million R$-234.81 Million R$-155.85 Million R$-190.30 Million
Net Receivables R$4.68 Billion R$2.71 Billion R$3.08 Billion R$2.75 Billion R$1.71 Billion
Inventory R$9.58 Billion R$8.41 Billion R$7.20 Billion R$6.13 Billion R$5.12 Billion
Property, Plant & Equipment R$7.28 Billion R$6.57 Billion R$5.94 Billion R$5.57 Billion R$5.33 Billion
Goodwill R$1.09 Billion R$1.06 Billion R$1.06 Billion R$1.08 Billion R$959.77 Million
Total Liabilities R$18.14 Billion R$15.70 Billion R$14.07 Billion R$11.78 Billion R$10.06 Billion
Total Current Liabilities R$10.19 Billion R$9.22 Billion R$8.08 Billion R$6.37 Billion R$5.90 Billion
Long-term Debt R$3.36 Billion R$2.66 Billion R$2.53 Billion R$2.13 Billion R$891.39 Million
Net Debt R$8.32 Billion R$7.17 Billion R$6.66 Billion R$5.62 Billion R$4.82 Billion
Total Stockholder Equity R$7.32 Billion R$6.43 Billion R$5.96 Billion R$5.34 Billion R$4.68 Billion
Retained Earnings R$283.18 Million R$2.25 Billion R$1.79 Billion R$167.53 Million R$2.07 Billion

Raia Drogasil S.A Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Raia Drogasil S.A generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow R$2.43 Billion R$1.91 Billion R$1.79 Billion R$1.68 Billion R$1.55 Billion
Capital Expenditures R$1.40 Billion R$1.28 Billion R$1.30 Billion R$1.19 Billion R$855.60 Million
Free Cash Flow R$1.03 Billion R$628.93 Million R$480.75 Million R$493.47 Million R$694.95 Million
Investing Cash Flow R$-1.41 Billion R$-1.41 Billion R$-1.31 Billion R$-1.23 Billion R$-885.95 Million
Financing Cash Flow R$-1.04 Billion R$-383.99 Million R$-499.42 Million R$-375.25 Million R$-1.20 Billion
Dividends Paid R$652.76 Million R$474.57 Million R$465.90 Million R$324.08 Million R$265.02 Million
Stock-Based Compensation R$27.98 Million R$38.03 Million R$33.22 Million R$22.60 Million R$15.09 Million
Depreciation R$2.01 Billion R$911.97 Million R$1.66 Billion R$1.52 Billion R$1.33 Billion
Change in Cash R$-18.38 Million R$115.68 Million R$-21.22 Million R$77.42 Million R$-524.24 Million

Raia Drogasil S.A Earnings History — EPS Actual vs. Analyst Estimates

Track Raia Drogasil S.A's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Aug 04, 2026 0.24
Mar 31, 2026 0.18 0.17 +1.32%
Mar 03, 2026 0.18 0.21 -14.29%
Nov 04, 2025 0.24 0.21 +14.29%
Aug 05, 2025 0.22 0.17 +29.41%
May 06, 2025 0.10 0.14 -28.57%
Feb 25, 2025 0.32 0.16 +100.00%
Nov 05, 2024 0.20 0.17 +17.65%